conduct survey core genet lab
manag focu sequenc
survey reveal volum expect
grow novaseq owner
deeper broader sequenc lab
novaseq consum revenu could doubl
support potenti upsid
interest technolog
well privat held ont
top pick convict sustain
double-digit sequenc consum growth
increas encourag strong
click enter text
click enter text
click enter text
click enter text
click enter text
click enter text
click enter text
annual core lab survey result boost confid upsid potenti
novaseq consum revenu forecast believ novaseq placement
forecast realist conserv survey posit
privat held ont survey less posit
neither aggress target core research lab
sampl volum growth expect approach novaseq
sampl volum growth expect approxim y/i exist
novaseq user sampl growth expect exceed y/i factor detail provid
includ placement believ core lab spend novaseq consum could
doubl
whole genom whole exom sequenc expect increas
portion sequenc sampl process also found interest singl
cell sequenc high-depth applic expect continu grow robustli also
note respond indic moderately/extrem like
perform deeper sequenc perform broader sequenc respect
averag expect consum spend per novaseq expect increas
believ support outlook
novaseq consum revenu growth market segment base
combin increas consum revenue/novaseq y/i
instrument increas instal base vs estim begin instal base
instrument note blend core lab forecast consum
revenu per novaseq accordingli could
argu survey support case upsid
survey affirm core lab import driver novaseq placement
demand remain robust custom segment believ support
novaseq placement outlook instrument among hiseq custom assumpt
origin hiseq lab order first novaseq one
placement order per new lab could low independ survey note
believ lab alreadi novaseq like account total
novaseq placement assum new high throughput adopt account
remain placement line histor trend
elast aliv capit servic cost remain potenti impedi
beyond aforement data demonstr grow demand sequenc data
sampl depth breadth survey respond indic import driver
motiv novaseq adopt lower cost/data addit survey
view reduct chip price launch lower volum
sp chip lower price per chip albeit higher price/data respect either
pleas see page report import disclosur
import somewhat import motiv novaseq purchas decis
said high capit cost believ associ servic cost novaseq remain
amongst biggest impedi instrument purchas requir mani sampl
also commonli note impedi expect get better new chip
dynam also explain lab consid send sampl site
novaseq accordingli see strong argument upsid potenti rel
novaseq consum forecast beyond survey suggest limit
upsid potenti novaseq placement forecast although interestingli
support pick pace placement
core survey instal base increas expect year beyond
follow platform ncounter sequel chromium oxford nanopor
ont promethion total five bgi/mgi instrument expect purchas
interest bit higher still low note core lab reveal
plan buy instrument small exist instal base ion torrent
instrument expect declin interest helio instrument
limit
core lab survey plan purchas spatial transcriptom platform
expect adopt geomx platform notabl one custom plan purchas
hyperion platform awar hyperion amongst survey low
also suspect capit cost impedi
survey respond use twst target captur product
overwhelmingli posit portfolio sever site indic plan evalu
futur reason interest coverag uniform complet
recent survey genet core lab manag answer question
regard futur usag adopt next gener sequenc
focu outlook ilmn novaseq remain key driver ilmn
growth outlook addit assess outlook demand non-ilmn
sequenc adjac technolog includ spatial-om twst target
survey conduct use qualtric survey research use cowen list
proprietari core lab manag
primarili survey manag genet core lab believ core lab
repres remain hiseq instrument instal base
therefor repres largest opportun estim across site
novaseq replac import area focu believ novaseq
placement util biggest variabl drive financi
perform rel current consensu expect next year
addit queri survey particip interest
platform oxford nanopor bgi/mgi interest
spatialom genom thought emerg player
note conduct similar survey accordingli
instanc opportun assess commun outlook evolv
sought answer follow question amongst other
mani sampl expect sequenc vs
expect mix applic
broad interest novaseq instrument
key driver key hesit novaseq adopt
import recent price chang product updat
novaseq purchas mani hiseq replac
expect consum spend per novaseq
interest evolv platform
privat held oxford nanopor genom bgi/mgi
level demand outlook spatialom platform
privately-held genom
driver purchas next gener sequenc captur kit
percept twst product
similar previou survey survey research
proprietari genet lab databas believ respond pool
particip repres core facil exist today
respond remain canada europ
asia
contrast previou survey requir respond still
least one hiseq instrument on-site inclus criteria want captur
custom contempl upgrad hiseq novaseq well
custom alreadi done importantli custom own hiseq
point
compar last survey elimin high-volum genom center
survey continu purpos target commerci lab instead
focus core lab believ lab account site middl
pyramid target replac instal base hiseq
novaseq note alreadi success drive novaseq placement
larg genom center new sequenc site accordingli note
design survey fulli captur sourc potenti novaseq demand
cowen compani
overal volum across respond expect grow y/i
increas expect custom
whole exom whole genom sequenc expect grow modestli
overal volum rna-seq like
remain domin applic decreas slightli
percentag overal volum
respond expect increas amount singl cell sequenc
perform lead increas sequenc demand rel
question mani sampl site sequenc
cowen compani annual genet tool lab survey june power qualtric
ask respond mani sampl expect run method
gaug growth rate overal industri increas project sampl
volum import albeit driver increas consum revenu
instrument demand
respond expect sampl
volum grow y/i notabl
respond novaseq expect
volum growth exceed y/i
result averag respond sequenc sampl
respond expect sampl volum grow y/i averag
sequenc sampl per respond interestingli site expect
novaseq instrument year-end expect sampl volum increas
y/i like affirm price elast function
replac ratio
takeaway consid expect sampl volum growth posit indic
overal market strength believ posit correl
expect signific volum increas expect higher
consum spend novaseq adopt absolut number sampl
year survey lower last year like last year survey
includ major genom center much higher volum averag core
lab number compar center exclud importantli
expect sampl growth rate y/i higher last year
question percentag sampl volum follow
figur split applic
cowen compani annual genet tool lab survey june power qualtric
ask respond current expect split volum
determin would shift toward comprehens sequenc
result rna-seq disproportion larg percentag sampl
volum past two year expect continu case
said whole genom sequenc expect increas
volum sequenc expect grow y/i
respond expect perform singl cell sequenc
takeaway result indic increas sequenc data gener
increas wgs/we y/i seem slight believ line previou
survey genom center exclud importantli respond expect
increas amount singl cell profil perform consid singl cell profil
requir sequenc individu cell experi rather sequenc
singl bulk sampl expect lead mark increas amount
data direct line initi nih fund sourc
wherebi agenc encourag research shift experi toward whole
genom whole exom sequenc singl cell profil drive
comprehens understand biolog novaseq rel higher capac
lower cost per gigabas like also support shift
comprehens sequenc increas capac demand plan
increas wes/wg y/i percentag
applic increas amount singl cell profil
perform encourag sign novaseq demand
key concern among consid novaseq purchas capac
requir attain lower price/data see fig
sampl increas capac demand plan increas
sampl run y/i demonstr demand
genet inform continu increas robustli believ also
help address investor concern novaseq capac requir
sampl volum growth
expect acceler depth
breadth sequenc per sampl also
expect increas lead
compound effect overal sequenc
novaseq consum revenu
site compound
increas placement
respond expect perform deeper sequenc
sampl novaseq respond expect perform
averag novaseq consum spend among respond expect
respect
half respond expect consum spend increas
addit novaseq
question like perform deeper broader sequenc sampl
novaseq
neither like unlik
cowen compani annual genet tool lab survey june
power qualtric
neither like unlik
ask respond either order plan order novaseq
like perform deeper sequenc increas sequenc coverag broader
sequenc sequenc nucleotid base per sampl sampl
determin novaseq would increas sequenc output
result respond queri indic like perform deeper
sequenc sampl respond believ unlik
similar last year survey
respond queri indic like perform broader
sequenc sampl respond believ unlik
similar last year survey
takeaway believ overwhelmingli strong respons due novaseq
high throughput capabl lower price/bas even rel hiseq
expect deeper sequenc broader sequenc addit expect
increas sampl volum bode well overal sequenc demand
beyond
question much anticip spend consum
novaseq instrument
cowen compani annual genet tool lab survey june power qualtric
theoret annual pull novaseq
novaseq
higher current overal
instrument forecast
ask respond anticip own novaseq expect
consum spend instrument come reason
approxim instrument pull-through next year
result averag expect consum spend novaseq instrument
lab chart indic respond expect wide
rang consum spend novaseq instrument expect spend
less per instrument expect spend per
novaseq instrument would note estim even
takeaway believ broad expect novaseq spend partli attribut
fact wide heterogen volum demand across
custom sever respond receiv novaseq later year
limit consum spend instrument second point
support find median expect consum spend
custom receiv novaseq instrument median
expect novaseq consum spend custom order expect
next month anyth believ could
upward bia pull-through estim consid survey larg exclud high
volum genom center commerci lab sever novaseq alreadi
implement instrument typic run much higher util
averag core facil recent indic top custom volum
overwhelmingli drive pull-through novaseq
novaseq pull-through guidanc provid estim
novaseq annuiti stream includ one-tim order
current forecast novaseq pull-through approxim
impli increas y/i materi lower survey data
suggest could sourc upsid rel model
question addit novaseq overal sequenc
consum spend chang
decreas
decreas
decreas
increas
increas
cowen compani annual genet tool lab survey june power qualtric
ask respond expect receiv novaseq
instrument would impact consum spend determin ultim
consum impact instrument ask question larg
determin increment novaseq revenu off-set lost hiseq revenu
result respond expect overal consum spend decreas
expect stay respond expect overal
consum spend increas respond expect
decreas also respond expect spend novaseq
consum
takeaway similar last year surpris half respond
expect consum spend increas consid near univers
expect volum increas sampl mix shift toward broader
sequenc deeper sequenc therefor seem possibl respond
still overestim rel reduct cost per gigabas novaseq
indic repeatedli hiseq custom move novaseq
purchas use consum previous ultim believ
reduct cost like off-set increas sampl volum
y/i increas expect among novaseq custom expect perform
broader deeper sequenc
revenu perspect
believ save /gb
outweigh sequenc deeper
sequenc broader sequenc
price per gb reduct shift hiseq novaseq includ recent price chang
total revenu pull-through impact due shift hiseq novaseq store
cowen compani annual genet tool lab survey june power qualtric
note analysi like captur impact hiseq cannib detail herein suggest overal novaseq consum revenu growth much higher
analysi survey data suggest core
lab could spend much novaseq
consum
survey data indic novaseq instal base core lab like
instrument ye expect grow ye base
survey data note figur respond spent plan spend
consum per novaseq instrument respect
taken togeth suggest total novaseq consum spend core lab
could approxim would growth y/i
describ tabl
assum core lab compris lower percentag novaseq placement
earli went high volum genom center
base cowen survey
 base cowen survey
estim core account consum revenu
 base cowen survey
base cowen survey
current forecast total novaseq consum revenu
off-set hiseq retir includ alreadi
cowen compani annual genet tool lab survey june power qualtric
novaseq custom expect perform deeper broader sequenc
believ due novaseq high throughput capabl
remind respond also expect perform sequenc fig
shift volum whole exom whole genom sequenc singl cell
sequenc fig expect deeper broader sequenc addit
two factor bode well overal sequenc demand
novaseq pull-through exceed although expect
vari custom receiv novaseq instrument expect
spend per instrument current forecast
novaseq annuiti stream therefor believ bia
upsid base survey data hiseq replac
current forecast given focus high
volum center given hypothet maximum annual
consum pull-through per novaseq exce factor
expect addit novaseq purchas discuss herein
believ core lab spend novaseq consum could doubl
overal consum spend like increas slightli half
respond expect consum spend increas
believ percentag higher overestim cost
save novaseq provid despit expect sequenc
broadli deeper increas volum
lower chip price launch sp chip help demand
detail herein later section
novaseq nextseq instal base expect grow among
respond progress increas expect novaseq stepwis
increas expect nextseq
respond hiseq instal base expect declin
attrit occur smaller progress decreas thereaft
cowen compani annual genet tool lab survey june power qualtric
ask respond provid expect instal base project
among sequenc portfolio instal base novaseq nextseq
expect increas within novaseq progress increas expect year
line ilmn guid expect cover later section
nextseq hand custom expect purchas instrument caus
instal base expand time
convers hiseq instal base expect
declin among respond also note seem miseq pressur
need assess follow up biggest declin instal
base expect occur also cover hiseq dynam
extens later section
respond expect novaseq
respond expect order novaseq next month
novaseq instal base among respond expect grow
y/i
question mani novaseq instrument site end
mani site expect end
cowen compani annual genet tool lab survey
june power qualtric
ask respond current expect novaseq order help level
set novaseq placement forecast next two year
result respond novaseq among respond
custom novaseq custom novaseq custom
survey indic respond novaseq
respond expect order novaseq next month
placement go custom novaseq previous
addit respond expect order novaseq next month
novaseq placement expect would growth y/i
expect instal base placement expect go
site alreadi exist novaseq instrument time
expect go lab expect novaseq
takeaway respond novaseq line
commentari indic hiseq custom purchas novaseq
believ custom origin hiseq instal base
start complet convers end would
step custom adopt survey indic
respond expect order novaseq next month
step respond own novaseq
believ adopt rate slightli like lower ilmn expect
survey genom center commerci lab note
major hiseq custom adopt novaseq exclud
custom impli guidanc call hiseq custom
convert believ within error bar survey would
increment origin hiseq custom would transit novaseq
origin hiseq custom
current model place instrument flat
number believ place therefor line
novaseq guidanc call placement flat slightli believ
survey support ilmn convers placement guidanc note tabl
support survey
respond hiseq expect order
novaseq one
previous origin
line histor trend
placement new high throughput
custom fy placement
base expect popul sequenc
ramp commerci lab util
could upsid visibl limit
cowen compani annual genet tool lab survey june power qualtric
interestingli survey result suggest even bigger step adopt expect
respond expect order novaseq next month
novaseq placement expect extrapol across entir hiseq
instal base translat instrument y/i growth placement
current model place instrument roughli flat
base survey result believ forecast could
potenti low
facil strong adopt novaseq survey site
order novaseq instrument time survey believ
demonstr enthusiasm success place instrument
custom categori
survey indic respond novaseq
believ line commentari histor hiseq
custom acknowledg survey purpos exclud major genom
center commerci lab
materi increas novaseq placement believ survey
result strong signal robust novaseq uptak among core lab
beyond current forecast place novaseq
flat y/i could potenti low
launch sp reduct
price chip expect
increas demand novaseq
main motiv purchas novaseq instrument low cost per
gigabas line previou survey importantli factor
view import
recent lower flow cell price recent launch sp flow cell
consid import drive purchas decis among
custom recent order novaseq
biggest hesitation/challeng novaseq purchas remain
instrument cost larg number sampl requir per run
achiev optim price/bas believ potenti opportun
differenti competitor
question site primari motiv purchas novaseq
desir need util date technolog
need anticip need add capac
abil retain bring sequenc hous
cowen compani annual genet tool lab survey june power qualtric
use scale import decis import decis
continu import driver
adopt affirm market elast
ask respond receiv order expect order
novaseq next month primari motiv behind purchas novaseq
instrument determin key driver novaseq adopt
result factor consid import base receiv score
novaseq lower cost per gigabas factor highest perceiv
import motiv novaseq purchas line survey
past year two factor increas import rel
last year survey flexibl abil retain/br sequenc hous
former seemingli driven broaden chip select
posit receiv survey respond see fig latter seem
lab increasingli purchas novaseq instrument stay competit
commerci vendor attract univers client sampl
outsourc altern affili core lab
reason provid respond includ forc obsolesc hiseq
increas chip price hiseq instrument make run
instrument less econom practic feasibl
takeaway unequivoc high import place novaseq abil
drive low cost per gigabas suggest elast continu aliv well
question import avail follow product drive
figur recent lower novaseq chip price
cowen compani annual genet tool lab survey june
power qualtric
ask respond receiv order expect order
novaseq next month ilmn flow cell price chang recent
launch sp flow cell determin import drive novaseq
result respond consid recent lower price
flow cell import drive decis purchas novaseq
respond indic import respond indic
novaseq sp flow cell began ship februari import novaseq
purchas decis respond note import
illumina book cowen compani
highli perceiv import
chang encourag consid
recent implement
takeaway consid result import lead indic futur novaseq
adopt util consid chip price occur
sp chip start ship
indic custom order sp chip combin
price chang open deepen mani convers
custom novaseq convers commentari well-support survey
result clearli result show core lab commun chang
chip well receiv
question site primari hesit purchas novaseq
per data point improv compel enough
concern chemistri qualiti
concern barcod index partit
lack single-end option shorter read length
consid send sampl anoth lab novaseq capac
anticip need add capac anytim soon
requir mani sampl
cowen compani annual genet tool lab survey june power qualtric
use scale import decis import decis
note lack single-end option shorter read-length consid send sampl anoth lab option last year survey
instrument cost sampl requir
two biggest caus
hesit purchas novaseq
ask respond novaseq instrument
plan buy novaseq instrument primari hesit understand
key barrier novaseq adopt
result instrument cost sampl requir biggest caus
hesit purchas novaseq rel last year sever factor decreas
import includ cost per data point chemistri barcoding/partit
concern instrument cost cost instrument servic contract written
respond anoth sourc hesit worri new
sequenc model releas soon also note concern coupl
respond ad new factor rel last year survey lack single-
end option shorter readlength consid send sampl anoth lab
novaseq capac factor consid import
takeaway survey result surpris close novaseq cost
hiseq repres signific capit expens
mani lab custom anticip use extra capac first third
import deterr like difficult justifi purchas
importantli attempt solv capac issu come
lower throughput chip lower chip price novaseq novaseq sp flow
cell gener littl gb data one run
maximum novaseq flow cell gener therefor sp flow cell would requir
far fewer sampl per run higher end chip note earlier section fig
improv lower end flow cell line-up well-
receiv custom
note appear decent proport manag contempl send
sampl anoth lab novaseq capac like reflect
strong price/bas elast also issu associ novaseq need
sequenc volum high capit cost
cowen compani
assum purchas novaseq instrument
elast aliv high import place novaseq
abil drive lower cost per gigabas suggest elast aliv
well core lab price/bas quicker run time drive
recent lower chip price sp chip consid import
launch ilmn low end sp flow cell lower chip price
consid import drive novaseq order believ
posit lead indic futur order consid product
hesit like lessen high perceiv instrument cost capac
demand continu deter core lab order novaseq instrument
howev believ barrier continu lessen demand
expect increas next sever year addit illumina
launch lower end chip reduc price low-end chip
lessen sampl requir invest lower end user perhap
lower price novaseq would make sens time
averag custom plan retir one hiseq instrument
novaseq purchas note seemingli consist
forecast hiseq retir
custom purchas novaseq made plan
hiseq retir point novaseq custom expect
question retir instrument plan retir
exist instrument due novaseq purchas order
one mani
cowen compani annual genet tool lab survey june
power qualtric
custom receiv novaseq alreadi retir
instrument retir instrument includ hiseq
respond retir instrument make averag replac
separ respond expect retir instrument futur
custom anticip retir instrument receiv
novaseq respond expect novaseq either
retir hiseq instrument point plan futur among
alreadi retir instrument novaseq half plan retir second
instrument futur cite rational previou anticip
retir among respond stop support instrument
custom also note less reason run hiseq alongsid novaseq
recent price chang rais price across hiseq flow cell
takeaway custom retir instrument slightli higher would
expect consid hiseq retir includ xs
novaseq placement far howev replac ratio
surpris consid respond hiseq instrument today fig
note hiseq decommiss seemingli
line pace hiseq retir expect
retir continu base survey result
current model hiseq retir could potenti low
novaseq adopt among hiseq user stronger anticip
note even advanc retir annual pull-through per hiseq includ
hiseq xs drop suggest either
underestim retir and/or use declin advanc
cowen compani annual genet tool lab survey june
power qualtric
replac ratio like remain user retir
sequenc follow novaseq purchas retir singl
custom hiseq instrument lab today
retir expect continu respond
own novaseq retir hiseq respond plan
novaseq intend eventu retir hiseq indic pace
hiseq retir like continu new novaseq instrument place
hiseq becom less support
instal base increas expect ncounter privately-held
oxford nanopor ont promethion privately-held genom
heighten interest ont genom also
interest also bgi/mgi although still limit
respond less interest ion torrent
year ago like function target clinic
opportun tradit core lab dont necessarili view
neg highlight import context
assess high end competit landscap
question mani follow instrument site end
mani site expect end
would describ site interest bring technolog hous
follow compani rel one year ago
note generead sequenc own expect among survey respond
cowen compani annual genet tool lab survey june power qualtric
ask respond instal base enthusiasm non-ilmn genet
analysi compani determin outlook interest busi
ion torrent adopt stall among respond expect
declin futur respond larg feel unchang interest
none respond plan generead instrument
surpris instrument gear toward clinic user
consist observ fact interest remain low technolog
core lab make sens given qgen focu juxtapos valu core lab put
wgs/we high-volum capabl
rsii instal base expect declin sequel instal base
expect remain flat slightli unexpect consid
recent launch sequel ii encouragingli respond interest
technolog like due sequel ii respond indic
would interest complet acquisit
oxford nanopor ont survey own either minion
promethion ont largest non-ilmn instal base among respond
expect increas base expect instal base growth
compar similarli half respond indic
interest bring oxford nanopor year ago
notabl given half respond consid purchas
oxford nanopor instrument last year custom interest
technolog last year survey well
instal base expect grow y/i core lab
somewhat surpris consid core lab primari target market
ncounter rather like individu lab sprint system howev
could driven strong demand nstg geomx digit spatial profil
today requir ncounter readout respond indic
interest nstg technolog year ago like due
addit updat releas regard geomx hyb seq
two custom survey pool own helio mass cytomet
custom indic less interest technolog
compar interest one respond expect
imag technolog spatialom see fig result
encourag would note mani mass cytometri placement
biopharma compani medic center two custom
group includ survey
bgi/mgi respond rel interest bgi/mgi sequenc
year ago fact two respond expect bgi/mgi sequenc
believ sequenc bgi/mgi platform like less expens
ilmn instrument howev would expect custom chemistri
concern bgi/mgi technolog consid chemistri concern factor
novaseq technolog see fig previou year unclear
bgi/mgi overcom sampl requir issu background
bgi/mgi sequenc portfolio updat pleas see page tool kit
link report
longer read system still interest heighten interest ont
lesser extent common denomin longer read
system respond indic would interest
complet acquisit compani privat held genom
also make traction placement custom interest
compani success penetr core lab market singl
cell enabl tool sequenc
interest increas ncounter placement expect
grow custom interest increas well believ
partli driven promis geomx digit spatial profil discuss
 less presenc core less interest
like explain focu core lab vs clinic
lab also limit interest
genom expect highest adopt among spatialom
product like due low cost entri
nanostr geomx product expect adopt
respond biggest driver adopt instrument abil
provid result singl experi previous requir multipl
experi case imposs
fluidigm hyperion imag expect purchas one
respond respond thought custom awar demand
low warrant purchas
question spatialom platform plan next
cowen compani annual genet tool lab survey june power qualtric
ask respond emerg spatialom platform
own plan purchas determin outlook busi
primer spatialom space pleas see recent report link cowen primer
respond plan purchas spatial transcriptom product
consid product commerci still somewhat nascent believ
speak genom strong reput research commun
attract low-cost way enter spatialom space
respond custom plan purchas fluidigm hyperion
custom plan buy instrument reason given custom
ask technolog among custom plan buy fluidigm
hyperion commonli cite reason custom ask
and/or awar low
custom ask
thought better spatial profil approach
allow research success grant fund
provid result previous possibl
believ provid addit valu
prefer spatial profil apprach
expens
custom ask awar low
cowen compani annual genet tool lab survey june power qualtric
respond plan purchas nanostr geomx instrument interestingli
one respond plan buy geomx plan also nanostr
ncounter instrument perhap indic user intend run sequenc
downstream analysi commonli cite reason adopt custom
profil provid result previous possibl
custom also indic enabl perform high throughput
multiplex similar fldm hyperion commonli select reason geomx
purchas custom ask it/awar low
addit sever custom regard clinic instrument readi prime-
time clinic diagnost platform requir heavi pathologist invest
dont medic school campu dont work ffpe sampl
written reason
allow research success grant fund
thought better spatial profil approach
provid result previous possibl
custom ask
believ provid addit valu
prefer spatial profil apprach
expens
custom ask awar low
cowen compani annual genet tool lab survey june power qualtric
nstg geomx placement driven uniqu perceiv valu
custom plan purchas geomx indic
provid result previous possibl howev awar
custom demand instrument still low
base survey result expect fewest
placement spatialom approach similar geomx
respond thought custom awar low
genom genom expect highest level
adopt among spatialom product expect consid
lowest barrier entri unexpect consid technolog
although metric consid import highli uniform captur
coverag complet coverag target region consid
import metric select captur kit
customiz captur kit consid least import
option still consid import
respond overwhelmingli posit captur
product sever plan tri product futur
question key driver select captur kit
panel highli customiz
workflow time sampl seq-readi short
kit highli valid
per reaction low
sequenc effici high
high sensit complet coverag target region
captur coverag highli uniform
cowen compani annual genet tool lab survey june power qualtric
ask respond key driver select platform
determin competit posit rel competitor
avail choic consid import respond respond
believ uniform captur coverag complet captur coverag
import driver select captur kit
question thought target captur product
use twist good impress compani
great potenti use lab
look like interest technolog
workflow rel easi
experi demand agil
use yet sinc still kinda new larg panel option set
intend valid exom near futur howev
read promis robust captur higher sequenc effici
ye good
tri soon
tri data gener yet
seem good person use
satisfi target captur product plan make chang
test
heard use
cowen compani annual genet tool lab survey june power qualtric
respond overwhelmingli posit captur
product respond use product time survey
sever posit compani thought technolog potenti
plan use product futur respond indic
satisfi current workflow plan tri product
current forecast gener revenu
respect impli strong growth year believ
survey result suggest custom demand real broad
sever metric import captur kit respond believ
provid metric import qualiti captur kit believ
captur product excel across metric therefor
well-receiv research commun
indic plan tri captur kit product
believ posit lead indic demand kit core lab across
globe current primarili drive revenu larg genom
center commerci lab therefor penetr core lab would tap
larg increment revenu stream
potenti drive materi revenu growth
current forecast gener revenu
respect impli strong growth year
believ survey result suggest custom demand real broad
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
